Newron Pharmaceuticals Logo

Newron Pharmaceuticals

🇮🇹
NWRN
IT0004147952

Newron Pharmaceuticals is a research-driven biopharmaceutical company based in Italy. It specializes in the development of innovative therapies for diseases of the central nervous system, focusing on novel medications for the treatment of various neurological and psychiatric conditions.

Next Quarterly Earnings

Tuesday, September 22, 2026
CW 39
Pre-Market
In 26 days
Confirmed by the company

Date confirmed from the company's own financial calendar.

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Currently in quiet period until September 22, 2026

Stock Price

Frequently asked questions

When will Newron Pharmaceuticals report its next quarterly earnings?

Newron Pharmaceuticals is scheduled to report its next quarterly earnings on 09/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Newron Pharmaceuticals last report quarterly earnings?

Newron Pharmaceuticals last reported quarterly earnings on 3/24/2026 (Q4 2025). Earnings per share (EPS) came in at -0.61 CHF.

How do I add the Newron Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:-CHF 0.18
Actual:
Q4 2025
Missed
Estimate:-CHF 0.07
Actual:-CHF 0.61
Difference:-CHF 0.54

Company Information

Name
Newron Pharmaceuticals
Ticker Symbol
NWRN
ISIN
IT0004147952
Country
🇮🇹
Italy
Sector